Schedule 13D ownership disclosure
CUE BIOPHARMA INC
Security class unavailable · CUSIP: 22978P106
Event date: 2021-07-25
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 6,251,645
- Percent of class
- 22.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001493152-23-026305
- Form type
- SC 13D
- Filer
- DIGIANDOMENICO ANTHONY
- CIK
- CIK 1083544
- Filed
- Aug 01, 2023
- Reporting period
- Jul 25, 2021
- Description
- Schedule 13D beneficial ownership